Manflu Limited 05002370 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is that of a dormant company. The company was dormant throughout the year. Digita Accounts Production Advanced 6.30.9574.0 true 05002370 2023-04-01 2024-03-31 05002370 2024-03-31 05002370 core:CurrentFinancialInstruments 2024-03-31 05002370 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 05002370 bus:SmallEntities 2023-04-01 2024-03-31 05002370 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 05002370 bus:FilletedAccounts 2023-04-01 2024-03-31 05002370 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 05002370 bus:RegisteredOffice 2023-04-01 2024-03-31 05002370 bus:Director1 2023-04-01 2024-03-31 05002370 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 05002370 core:KeyManagementPersonnel 2023-04-01 2024-03-31 05002370 countries:EnglandWales 2023-04-01 2024-03-31 05002370 2022-04-01 2023-03-31 05002370 core:CurrentFinancialInstruments 2023-03-31 05002370 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 05002370

Manflu Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2024

 

Manflu Limited

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2

 

Manflu Limited

(Registration number: 05002370)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

200

200

Capital and reserves

 

Called up share capital

200

200

Shareholders' funds

 

200

200

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 11 September 2024
 

.........................................
Mr P B Davies
Director

 

Manflu Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 3C Enterprise Way
Airedale Business Centre
Skipton
North Yorkshire
BD23 2FJ
England

These financial statements were authorised for issue by the director on 11 September 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

4

Debtors

Current

2024
£

2023
£

Other debtors

200

200

 

200

200

5

Related party transactions

Health and Wellbeing Brands Ltd
(Parent Company)

There were no disclosable transactions during the year. At the year end the balance outstanding was £200 (2023 - £200).